SimCardioTest
Simulation of Cardiac Devices & Drugs for in-silico Testing and Certification
Duration
2021-2025
Coordinated by
INRIA
Projects Partners
9
Project funding
7.9M €
The Project
SimCardioTest is a pioneering EU-funded initiative demonstrating the feasibility, effectiveness, and regulatory potential of in silico clinical trials for cardiovascular devices and drugs. Bringing together partners from Belgium, Spain, France, Italy, Norway, and the United States, the project builds trust among regulators, clinicians, patients, and industry by showing how verified and validated simulations can accelerate innovation. By aligning computational results with real clinical data, SimCardioTest addresses key challenges in uncertainty quantification, regulatory compliance, and the development of safer, more effective cardiovascular therapies.
Our role in the project
As a core partner, VPH led the project’s Exploitation, Dissemination, and Communication activities, ensuring that SimCardioTest’s results reached regulatory authorities, healthcare professionals, industry leaders, and the broader scientific community. We drove high-impact outreach, strengthened collaboration between stakeholders, and contributed strategically to the project’s technical development to foster real-world adoption of simulation-based solutions.